Cite
MLA Citation
Antonia Beitzen-Heineke et al.. “AXL Inhibition Represents a Novel Therapeutic Approach in BCR-ABL Negative Myeloproliferative Neoplasms.” HemaSphere, vol. 5, no. 9, 2021, pp. e630–. http://access.bl.uk/ark:/81055/vdc_100145478906.0x000011